Menu
23 May 2019 | 5:27 PM
 

Indoco Remedies Ltd. Share Price Live (BSE)
0

BSE Code: 532612 | NSE Symbol: INDOCO
182.00
-0.80
(-0.43 %)
23 May 2019 | 04:01 PM
Change company
  • Open (Rs)
    183.10
  • Prev. close (Rs.)
    182.80
  • High (Rs.)
    185.50
  • Low (Rs.)
    182.00
  • 52W H (Rs.)
    238.00
  • 52W L (Rs.)
    150.25
  • Volume
    1377
  • MCap (Rs in Cr.)
    1,677.13
F&O Futures F&O Options
Expiry Date
0
0.00
(0.00 %)
  • Open (Rs)
    0.00
  • High (Rs)
    0.00
  • Low (Rs)
    0.00
  • Prev. close(Rs)
    0.00
  • Contracts Tra.
  • Turnover (Cr.)
    N.A.
  • Open Interest
  • Open Int. chg
    0.00
1D| 1W| 1M | 3M | 6M | 1YR | MAX

Financials

EPS
4.47
Operating Margin (%)
12.95
Gross Profit Margin (%)
6.45
Net Profit Margin (%)
3.95
Total Debt/Equity
0.35
Dividend payout Ratio (Net Profit)
43.11
Earning Retention Ratio
56.89

News

Indoco Remedies has submitted to BSE the Shareholding Pattern for the Period Ended March 31 2019
11 May 2019 - 13:50:00-As of March 2019 58.67% is owned by Indian Promoters and 41.32% by Public...
Indoco Remedies Q3 net profit down 76.43% at Rs 5.34 cr
23 Jan 2019 - 12:30:00-The company reported standalone net profit of Rs 5...
Indoco Remedies gets two minor observations from USFDA for Goa plants
22 Nov 2018 - 17:10:00-Drug firm Indoco Remedies Thursday said it has received two minor observations from the US health re...
Indoco Remedies Q4 net profit up 14.27% at Rs 20.50 cr
30 May 2018 - 13:00:00-The company reported standalone net profit of Rs 20...

Announcements

22-May-2019
Indoco Remedies - Analysts/Institutional Investor Meet/Con. Call Updates
15-May-2019
Indoco Remedies - Board Meeting Intimation for Approval Of Audited Financial Results For The Year Ended 31St March 2019 And
08-May-2019
Indoco Remedies - Press Release
08-May-2019
Indoco Remedies - Announcement under Regulation 30 (LODR)-Press Release / Media Release
24-Apr-2019
Indoco Remedies - Announcement under Regulation 30 (LODR)-Press Release / Media Release

Religare Research

Agri Fundamental & Technical Report
28 Feb 2019 | 10:15 AM
• Agri markets kept trading with high volatility with no strong directions, even as prices seem to f...
Agri Fundamental & Technical Report
04 Feb 2019 | 11:57 AM
Agri Fundamental & Technical Report
Weekly Report ( Metals & Energy) Jan 21-Jan 25 2019
21 Jan 2019 | 07:35 PM
Weekly report
Weekly Report ( Metals Energy ) 7th Jan 2019 11th Jan 2019
07 Jan 2019 | 06:56 PM
Gold prices fell on Friday, pulling back from more than a six-month peak hit earlier in the session,...

Fund Interest

Schemes Shares Held Mkt. Value Latest Nav % Nav
29,13,658 98.26 29.27 0.44
29,13,658 98.26 54.54 0.44
29,13,658 98.26 56.75 0.44
29,13,658 98.26 30.48 0.43
17,36,533 58.56 48.69 0.16

Shareholding Pattern

       
Promotors58.68%
Mutual Funds/UTI12.72%
FI/Banks2.05%
Insurance2.05%
FII2.12%
Government0.00%
Others5.20%

Peer Group

Company Intraday Graph
 Hester Biosciences Ltd.
1,570.00(-2.56)
 3572
 Kovai Medical Center and Hospital Ltd.
799.10(8.79)
 11816
 Novartis India Ltd.
716.75(0.85)
 2647
 DIL Ltd.
677.00(2.36)
 3299

Exchange Information

NSE Index
Sensex
CNX 100
BSENAT
CNX 200
BSE200
CNX Bank
BSE500
CNX500
BSE Midcap
CNX Midcap
BSE Smallcap
Note: The scrip is a constituent of those NSE and BSE indices that have against them.

Company Indices

 1M (%)3M (%)6M (%)
Indoco Remedies Ltd.-16.408.50-24.40
NIFTY(S&P CNX)62.60865.401,130.30
BSE SENSEX166.212,939.913,830.37
BSE 500-84.13986.441,043.73

Corporate Details

Key Personal
Aditi Panandikar
Managing Director
Anand Nadkarni
Non Executive Director
Sundeep V Bambolkar
Joint Managing Director
Key Address
Registered Office
Indoco House 166 CST Road Kalina Santacruz (East),Mumbai,Maharashtra

Tel:022-26541851 26541852 26541853 26541854 26541855, Fax:022-26520787 66936241

compliance.officer@indoco.com
http://www.indoco.com
Registrar Office
Link Intime India Pvt. Ltd.
Add. :C 101 247 Park L.B.S. Marg Vikhroli (West)
QUICK LINKS
RELIGARE ONLINE
IMPORTANT LINKS
EXPLORE RELIGARE
Stocks Directory
Mutual Funds Directory
Investor Complaints
Attention Investors

Prevent unauthorized transactions in your account - Update your mobile numbers/email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day - Issued in the interest of Investors.

Prevent Unauthorized Transactions in your demat account Update your Mobile Number with your Depository Participant. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from Depository (NSDL/CDSL) on the same day issued in the interest of investors.

No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investors account.

KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.

Trading and Demat Accounts opened under Insta Plan will not be eligible for dealing through branches.

Kindly update your aadhar with us here. UPDATE AADHAAR
Follow us on
Unified Portal Version No.1.0.0.1
Copyright 2010 Religare. Trademarks are the property of their respective owners. All rights reserved.
Religare Broking Limited, Registered Office:2nd Floor, Rajlok Building, 24, Nehru Place, New Delhi-110019. Board line number 011-46272400, Fax No. 011-46272447
Broking Business of Religare Securities Ltd ( RSL) has been transferred and vested in Religare Broking Limited ( RBL) , pursuant to NCLT order.
  • Religare Broking Limited (RBL)*:
  • SEBI Regn No. INZ000174330  |  NSE CM, F&O, CD TM Code: 06537 Clearing Member (F&O) No. M50235  |  BSE CM, F&O, CD Clearing No: 3004  |  MSE CM, F&O, CD TM Co: 1051 Clearing Member (F&O) No. 51  |  AMFI ARN No. 139809
  • Depository Participant –
  • NSDL: DP ID: IN 301774  |  SEBI Regn. No: IN-DP-385-2018  |  CDSL DP ID: 30200  |  SEBI Regn. No: IN-DP-385-2018
  • Religare Broking Limited (RBL):
  • Research Analyst SEBI Regi. No.: INH100006977
    Religare Commodities Limited- Registered Office:2nd Floor, Rajlok Building, 24, Nehru Place, New Delhi-110019. Board line number 011-46272400, Fax No. 011-46272447
  • Member :
  • NCDEX: Member ID - 00109 |
  • MCX: Member ID - 10575 |
  • SEBI Registration Number- INZ000022334|
  • NSEL Member ID- 10180 |
  • Neml Member ID - 10042
The Site is best viewed with screen resolution 1024x768. The compatible browsers are Mozilla Firefox, Google Chrome and IE 8 (or above)